Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 50,000 shares at $1.70 ($85K) on 2016-08-26, disclosed to the SEC on 2016-08-30.
Open-market sale of $85k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.70 | 12,998 | $22K | 25.8% |
| 2 | $1.71 | 12,002 | $21K | 24.0% |
| 3 | $1.71 | 12,500 | $21K | 25.0% |
| 4 | $1.72 | 12,500 | $22K | 25.1% |
| Total | $1.71 avg | 50,000 | $85K | 100% |
| Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |
| ATNM | SELL | 2016-07-07 | $38K | — | Filing → |